Moderna plans to prioritize new product approvals and oncology investments, as political concerns over Robert F. Kennedy Jr.'s HHS nomination weigh on vaccine stocks.

Piper Sandler lowered the firm’s price target on Moderna (MRNA) to $69 from $115 and keeps an Overweight rating on the shares. The firm notes ...

For young, healthy people who may be wondering, “do I need a COVID booster at all?”, having one annually is sensible.

If you missed the early fall push for flu and COVID-19 vaccines, it’s not too late. Health officials say it’s important to ...

Stacker consulted research from Yale Medical School and the World Health Organization to find how SARS-CoV-2 has evolved ...

The number of COVID cases increased last week to 146. Cases had been falling in April and May and were as low as 31 at the ...

Two Delaware schools have been nationally recognized for closing the achievement gap and supporting the academic growth of ...